Common (Usually Transient) Side Effects Water retention or puffiness Carpal tunnel-like symptoms Joint stiffness (often temporary) Mild insulin resistance if overdosed How We Monitor Baseline and follow-up IGF-1 levels Body composition changes Symptom tracking and dose titration Our goal is to maintain IGF-1 in the high-normal physiologic range , not to create supraphysiologic levels
GLOW Blend peptide therapy is prescribed only when clinically appropriate after provider evaluation
Composition VII
In a recent study, participants taking semaglutide were able to lose an average of 10.8 percent of their body weight over the course of 56 weeks, while those taking a placebo only lost 0.9 percent
Its rich in proteins such as antibodies, albumin, and clotting factors vital to various medical treatments and procedures
Dr Amanda Lim, a consultant in the division of endocrinology at the National University Hospital, noted that previously, lifestyle interventions might result in weight loss of around 3 to 8 per cent
